Tokyo Tape
Sign in
← Cyfuse Biomedical

Half-year report · Q2

4892.TEDINET S100U843
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥18m2024-01-01 → 2024-06-30StandaloneNet sales
Revenue¥61m2023-01-01 → 2023-12-31StandaloneNet sales (5-year summary)
Revenue¥18m2023-01-01 → 2023-06-30StandaloneNet sales
Operating income−¥449m2024-01-01 → 2024-06-30StandaloneOperating income
Operating income−¥364m2023-01-01 → 2023-06-30StandaloneOperating income
Ordinary income−¥446m2024-01-01 → 2024-06-30StandaloneOrdinary income
Ordinary income−¥586m2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥363m2023-01-01 → 2023-06-30StandaloneOrdinary income
Profit before tax−¥446m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Profit before tax−¥363m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Net income−¥447m2024-01-01 → 2024-06-30StandaloneProfit loss
Net income−¥589m2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income−¥365m2023-01-01 → 2023-06-30StandaloneProfit loss
Total assets¥3.8bnat 2024-06-30StandaloneAssets
Total assets¥4.2bnat 2023-12-31StandaloneAssets
Total assets¥4.4bnat 2023-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥914mat 2024-06-30StandaloneLiabilities
Total liabilities¥1.0bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥2.9bnat 2024-06-30StandaloneNet assets
Net assets / equity¥3.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥3.4bnat 2023-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥3.4bnat 2024-06-30StandaloneCash and deposits
Cash and deposits¥3.9bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥2.4bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.9bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥3.1bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥3.4bnat 2022-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥372m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥562m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥316m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥8m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥19m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥11m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥109m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥18m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥53m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-56.152024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-75.422023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-46.732023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio75.6%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.0%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.7%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued8,130,800at 2024-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued7,894,300at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued7,813,800at 2023-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 407
ItemContextValueUnit
Decrease increase in consumption taxes receivable payable ope cfCurrentYTDDuration_NonConsolidatedMember10115000JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember-18939000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember153000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember-339024000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-395726000JPY
Interest income received ope cfPrior1YTDDuration_NonConsolidatedMember17000JPY
Interest income received ope cfCurrentYTDDuration_NonConsolidatedMember29000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-4758000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-4523000JPY
Proceeds from subsidy ope cfPrior1YTDDuration_NonConsolidatedMember30266000JPY
Proceeds from subsidy ope cfCurrentYTDDuration_NonConsolidatedMember31021000JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-2441000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-2542000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember-315940000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-371740000JPY
Payments for lease and guarantee deposits inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Payments for lease and guarantee deposits inv cfCurrentYTDDuration_NonConsolidatedMember-90000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration_NonConsolidatedMember-11347000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember-6796000JPY
Purchase of intangible assets inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Purchase of intangible assets inv cfCurrentYTDDuration_NonConsolidatedMember-934000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration_NonConsolidatedMember-11347000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember-7821000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember-54132000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember-9000000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember-4736000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember-104789000JPY
Proceeds from issuance of common stock fin cfPrior1YTDDuration_NonConsolidatedMember5450000JPY
Proceeds from issuance of common stock fin cfCurrentYTDDuration_NonConsolidatedMember3430000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember1550000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember-53418000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember-108809000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember-380706000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-488370000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember3437307000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember2873773000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember3056601000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember2385402000JPY
Directors compensations sgaPrior1YTDDuration_NonConsolidatedMember57937000JPY
Directors compensations sgaCurrentYTDDuration_NonConsolidatedMember57450000JPY
Salaries allowances and bonuses sgaPrior1YTDDuration_NonConsolidatedMember21277000JPY
Salaries allowances and bonuses sgaCurrentYTDDuration_NonConsolidatedMember23276000JPY
Share based compensation expense major components of selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember－JPY
Share based compensation expense major components of selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember28547000JPY
Rents sgaPrior1YTDDuration_NonConsolidatedMember12519000JPY
Rents sgaCurrentYTDDuration_NonConsolidatedMember12808000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember182566000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember231804000JPY
Business consignment expenses sgaPrior1YTDDuration_NonConsolidatedMember30083000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-12-31pass rounding
balance sheet identitynon_consolidated 2024-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-06-30pass